Home›Trial›NCT05946941

🔬NCT05946941Phase 3ACTIVE NOT RECRUITING

A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome

Study Summary

The purpose of this study is to assess the safety and efficacy of two doses of Deucravacitinib in adult participants with Active Sjögren's Syndrome.

Conditions

Sjögren's Syndrome

Interventions / Drugs

Deucravacitinib Placebo

View on ClinicalTrials.gov ↗

Sponsor

Bristol-Myers Squibb

Study Details

Enrollment774 participants

Primary Completion—

Lead SponsorBristol-Myers Squibb

Data Retrieved2026-04-11 04:08:14.746320+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.